Listed here, we describe a pharmacogenetics method that allows to selectively and reversibly inactivate LC neurons utilizing Designer Receptors Exclusively Activated by Designer Medicine (DREADD). We show that the expression of the hM4Di DREADD can be limited to noradrenergic LC neurons and that the quantity of LC inhibition could be https://davidi520edb9.frewwebs.com/profile